13.01.2011
- Merck & Co struck an alliance with contract researcher Parexel International to develop copies of biotech medicines, deepening the U.S. drugmaker's investment in so-called...
Former Millipore executive Dominique Baly, has assumed cross-divisional management of marketing, sales and service for the Sartorius laboratory business as president of...
11.01.2011
- Genzyme acknowledged on Monday that it was discussing a takeover deal with French drugmaker Sanofi-Aventis, but hopes for a quick agreement cooled as both sides noted differences...
11.01.2011
- Novartis advanced its bid to copies Roche's multi-billion dollar antibody drug rituximab on Monday, starting phase II trials for its own version of the blockbuster medicine. Drugs...
10.01.2011
- French drugmaker Sanofi-Aventis and Genzyme Corp are discussing options for significantly raising Sanofi's bid for the the U.S. biotech company to about $80 per share, the Wall...
07.01.2011
- Monsanto, the world's largest seed company, said on Thursday that a line-up of new biotech seed products have the company well positioned for future growth. St. Louis, Mo.-based...
21.12.2010
- Novozymes, the world's top industrial enzymes maker, is buying U.S. based EMD/Merck Crop BioScience for $275 million from Merck KGaA , boosting its presence in the fast-growing...
21.12.2010
- Genzyme argued that its experimental multiple sclerosis treatment will garner far higher sales than Sanofi-Aventis is projecting, as it aims to wrest a significantly higher bid...
15.12.2010
- French drugmaker Sanofi-Aventis is in talks to invest in Hadasit Bio-Holdings, the Israeli biotech holding company said on Tuesday. Hadasit said the potential investment would be...
14.12.2010
- Sanofi-Aventis named Elias Zerhouni as its new head of research and development as the French drugmaker reshapes its drug portfolio to offset sales losses from patent expiries...
